Synthesis and biological evaluation of novel 2-azido muramyl dipeptide as NOD2 agonistic adjuvants.
2-AZMDP(1-5)
Bio-isosters
CD4
CD8
DENV
MDP
NOD2 agonist
Journal
Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298
Informations de publication
Date de publication:
15 07 2022
15 07 2022
Historique:
received:
15
12
2021
revised:
22
04
2022
accepted:
23
04
2022
pubmed:
16
5
2022
medline:
3
6
2022
entrez:
15
5
2022
Statut:
ppublish
Résumé
Novel 2-Azido muramyl dipeptide was synthesized by the bio-isosteric replacement of the N-acetyl group of the muramic acid fragment with the azide functionality at the C2 position. In order to examine the effect of hydrophilic-lipophilic balance on the adjuvant activity, derivatives were synthesized by removing protecting groups sequentially to tune the polarity. Amongst five novel azido derivatives of MDP studied here, di- and mono-benzylated azido derivatives 10 and 11 exhibited good DENV specific antibody(IgG) response with Th1 polarization compared to parent compound Muramyl dipeptide (MDP) whereas all five new derivatives responded positively to NOD2 agonistic assays with compound 10 showing highest stimulation.
Identifiants
pubmed: 35569249
pii: S0968-0896(22)00173-0
doi: 10.1016/j.bmc.2022.116781
pii:
doi:
Substances chimiques
Adjuvants, Immunologic
0
Adjuvants, Pharmaceutic
0
Nod2 Signaling Adaptor Protein
0
Acetylmuramyl-Alanyl-Isoglutamine
53678-77-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
116781Informations de copyright
Copyright © 2022. Published by Elsevier Ltd.